title: Second hematological malignancies during arsenic trioxide therapy of B-cell lymphomas.
authors.forename: Wing-Yan
authors.initials: WY
authors.lastname: Au
authors.forename: Sidney
authors.initials: S
authors.lastname: Tam
authors.forename: Bonnie M W
authors.initials: BM
authors.lastname: Fong
authors.forename: Thomas S K
authors.initials: TS
authors.lastname: Wan
authors.forename: Sze-Fai
authors.initials: SF
authors.lastname: Yip
authors.forename: Yok-Lam
authors.initials: YL
authors.lastname: Kwong
mesh_terms: D000368:Aged; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D019337:Hematologic Neoplasms / Q000139:chemically induced*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D010087:Oxides / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide